Chemoinformaics analysis of beta-Butyrolactone
| Molecular Weight | 86.09 | nRot | 0 |
| Heavy Atom Molecular Weight | 80.042 | nRig | 5 |
| Exact Molecular Weight | 86.0368 | nRing | 1 |
| Solubility: LogS | -0.89 | nHRing | 1 |
| Solubility: LogP | 0.495 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 12 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 12.2848 |
| nHD | 0 | BPOL | 8.62324 |
| QED | 0.397 |
| Synth | 2.674 |
| Natural Product Likeliness | 1.986 |
| NR-PPAR-gamma | 0.064 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.431 |
| MDCK | 0.0000749 |
| BBB | 0.996 |
| PPB | 0.114514 |
| VDSS | 0.791 |
| FU | 0.802521 |
| CYP1A2-inh | 0.301 |
| CYP1A2-sub | 0.108 |
| CYP2c19-inh | 0.038 |
| CYP2c19-sub | 0.599 |
| CYP2c9-inh | 0.009 |
| CYP2c9-sub | 0.163 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.423 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.259 |
| CL | 10.672 |
| T12 | 0.86 |
| hERG | 0.006 |
| Ames | 0.787 |
| ROA | 0.064 |
| SkinSen | 0.667 |
| Carcinogencity | 0.905 |
| EI | 0.989 |
| Respiratory | 0.056 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.959361 |